Analyze of factors and prognosis of eyes lost to follow-up in retinal vein occlusive disease patients receiving anti-vascular endothelial growth factor therapy

BACKGROUND: Patients with macular edema (ME) secondary to retinal vein occlusion (RVO) who received at least one intravitreal injection of anti-vascular endothelial growth factor therapy (VEGF) and lost to follow-up (LTFU) for more than six months were analyzed to investigate the factors contributin...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xiaoying, Zheng, Minming, Lu, Jiatao, Wang, Xi, Zheng, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258483/
https://www.ncbi.nlm.nih.gov/pubmed/37308854
http://dx.doi.org/10.1186/s12886-023-03018-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258483/
https://www.ncbi.nlm.nih.gov/pubmed/37308854
http://dx.doi.org/10.1186/s12886-023-03018-9

Ejemplares similares